%PDF-1.4
%
59 0 obj
<>
endobj
56 0 obj
<>
endobj
143 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2003-07-29T18:26:54Z
2024-03-28T21:46:02-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-28T21:46:02-07:00
application/pdf
Heather
2002-258.sept
uuid:686b71be-1dd2-11b2-0a00-480827bd7700
uuid:686b71c0-1dd2-11b2-0a00-900000000000
endstream
endobj
45 0 obj
<>
endobj
46 0 obj
<>
endobj
60 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 31 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 33 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 35 0 R/Type/Page>>
endobj
17 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 37 0 R/Type/Page>>
endobj
25 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 39 0 R/Type/Page>>
endobj
162 0 obj
[167 0 R]
endobj
163 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
0 0 0 0 k
/GS1 gs
420 777 137 -27 re
f*
0 0 0 1 K
54 54 m
558 54 l
S
BT
0 0 0 1 k
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 424.3613 35.9844 Tm
(The Journal of Rheumatology 2003; 30:9)Tj
0 Tc 0 Tw -46.2952 -0.0313 Td
(2058)Tj
ET
0 0 0 0 k
/GS0 gs
109.25 59.1 396.47 -10.84 re
f*
0.5 w
109.25 59.1 396.47 -10.84 re
S
BT
0 0 0 1 k
/GS1 gs
/T1_1 1 Tf
-0.00011 Tc 0.08051 Tw 10 0 0 10 54 713.1616 Tm
[(ef)18 (fect on outcome and severity of disease \(as measured by)]TJ
0.0056 Tw 0 -1.2 TD
[(disease activity)65 (, function, and radiology\), or that outcome is)]TJ
0.2231 Tw T*
(influenced if the transmission is maternal as opposed to)Tj
0.02499 Tw T*
(paternal \(Figure 2\). )Tj
0.0558 Tw 1.2 -1.2 Td
[(Our results show that families where the mother has )55 (AS)]TJ
0.2372 Tw -1.2 -1.2 Td
[(contain more heritable factors than families with an )55 (AS)]TJ
0.1879 Tw T*
[(father)55 (. In addition, disease transmitted from the maternal)]TJ
0.3228 Tw T*
[(side does not dif)18 (fer from disease transmitted from the)]TJ
0.0602 Tw T*
[(paternal side in male patients in terms of severity)65 (. In terms)]TJ
0.1763 Tw T*
[(of susceptibility)65 (, however)40 (, disease among female patients)]TJ
0.05721 Tw T*
[(may dif)18 (fer)40 (, as there are fewer susceptibility genes from the)]TJ
0.15849 Tw T*
(paternal side and daughters are less likely to develop the)Tj
0.0481 Tw T*
[(condition. Of)18 (fspring of women with )55 (AS develop more IBD)]TJ
0.0006 Tw T*
[(and sons of men with )55 (AS develop more psoriasis, indicating)]TJ
0.20399 Tw T*
[(that there is a gender ef)18 (fect on inheritance of secondary)]TJ
0.02499 Tw T*
[(conditions associated with )55 (AS.)]TJ
/T1_2 1 Tf
0 Tw 0 -2.4 TD
(REFERENCES)Tj
/T1_1 1 Tf
0.02499 Tw 8 0 0 8 61.6 499.1616 Tm
[(1.)-500 (W)80 (ordsworth P)111 (, Brown M. HLA-B27, ankylosing spondylitis, and the)]TJ
1.25 -1.25 Td
[(spondyloarthropathies. In: Calin )55 (A, )18 (T)70 (aurog J, editors. )18 (The )]TJ
0 -1.25 TD
(spondylarthritides. Oxford: Oxford University Press; 1998:179-93.)Tj
-1.25 -1.25 Td
[(2.)-500 (Brewerton D, Hart F)80 (, Nicholls )55 (A, Caf)18 (frey M, James D, Sturrock R.)]TJ
1.25 -1.25 Td
(Ankylosing spondylitis and HLA-27. Lancet 1973;1:904-7.)Tj
-1.25 -1.25 Td
[(3.)-500 (Calin )55 (A, Marder )55 (A, Becks E, Burns )18 (T)74 (. Genetic dif)18 (ferences between)]TJ
1.25 -1.25 Td
(B27 positive patients with ankylosing spondylitis and B27 positive)Tj
T*
[(healthy controls. )55 (Arthritis Rheum 1983;26:1460-4.)]TJ
-1.25 -1.25 Td
[(4.)-500 (van der Linden S, )18 (V)111 (alkenbur)18 (g H, de Jongh B, Cats )55 (A. )18 (The risk of)]TJ
1.25 -1.25 Td
[(developing ankylosing spondylitis in HLA)-220 (B27 positive individuals:)]TJ
T*
(a comparison of relatives of spondylitis patients with the general)Tj
T*
[(population. )55 (Arthritis Rheum 1984:27:241-9.)]TJ
-1.25 -1.25 Td
[(5.)-500 (Brown M, Pile K, Kennedy G, et al. )55 (A)-220 (genome-wide screen for)]TJ
1.25 -1.25 Td
[(susceptibility loci in ankylosing spondylitis. )55 (Arthritis Rheum)]TJ
0 Tc 0 Tw T*
(1998;41:588-95.)Tj
-0.00011 Tc 0.02499 Tw -1.25 -1.25 Td
[(6.)-500 (Rubin L, )55 (Amos C, )18 (W)80 (ade J. Investigating the genetic basis for )]TJ
1.25 -1.25 Td
(ankylosing spondylitis. Linkage studies with the major )Tj
T*
[(histocompatibility complex region. )55 (Arthritis Rheum )]TJ
0 Tc 0 Tw T*
(1994;37:1212-20.)Tj
-0.00011 Tc 0.02499 Tw 31.75 49.421 Td
[(7.)-500 (Laval S, )18 (T)35 (imms )55 (A, Edwards S, et al. )18 (Whole-genome screening in)]TJ
1.25 -1.25 Td
(ankylosing spondylitis: evidence of non-MHC genetic susceptibility)Tj
T*
[(loci. )55 (Am J Hum Genet 2001;68:918-26.)]TJ
-1.25 -1.25 Td
[(8.)-500 (Brown M, Laval S, Brophy S, Calin )55 (A. Recurrence risk modelling of)]TJ
1.25 -1.25 Td
[(the genetic susceptibility to ankylosing spondylitis. )55 (Ann Rheum Dis)]TJ
0 Tc 0 Tw T*
(2000;59:883-6.)Tj
-0.00011 Tc 0.02499 Tw -1.25 -1.25 Td
[(9.)-500 (Gran J, Husby G, Hordivik M, Stormer J, Romber)18 (g-Andersen O.)]TJ
1.25 -1.25 Td
(Radiological changes in men and women with ankylosing)Tj
0 Tc T*
[(spondylitis. )55 (Ann Rheum Dis 1984;43:570-5.)]TJ
-0.00011 Tc -1.75 -1.25 Td
[(10.)-500 (T)70 (aylor )55 (A, Balakrishnan C, Calin )55 (A. Reference centile charts for)]TJ
1.75 -1.25 Td
[(measures of disease activity)65 (, functional impairment, and metrology)]TJ
T*
[(in ankylosing spondylitis. )55 (Arthritis Rheum 1998;41:1)37 (1)37 (19-25.)]TJ
-1.7131 -1.25 Td
[(1)37 (1.)-500 (Calin )55 (A, Brophy S, Blake D. Impact of sex on inheritance of )]TJ
1.7131 -1.25 Td
[(ankylosing spondylitis: a cohort study)65 (. Lancet 1999;354:1687-90.)]TJ
-1.75 -1.25 Td
[(12.)-500 (Miceli-Richard C, Said-Nahal R, Breban M. Impact of sex on )]TJ
1.75 -1.25 Td
(inheritance of ankylosing spondylitis. Lancet 2000;355:1097-8.)Tj
-1.75 -1.25 Td
[(13.)-500 (Garrett S, Jenkinson )18 (T)74 (, Kennedy G, )18 (Whitelock H, Gaisford P)111 (, Calin)]TJ
1.75 -1.25 Td
[(A. )55 (A)-220 (new approach to defining disease status in ankylosing)]TJ
T*
[(spondylitis: )18 (The Bath )55 (Ankylosing Spondylitis Disease )55 (Activity)]TJ
T*
(Index. J Rheumatol 1994:21:2286-91.)Tj
-1.75 -1.25 Td
[(14.)-500 (Calin )55 (A, Garrett S, )18 (Whitelock H, et al. )55 (A)-220 (new approach to defining)]TJ
1.75 -1.25 Td
[(functional ability in ankylosing spondylitis: )18 (The development of the)]TJ
T*
[(Bath )55 (Ankylosing Spondylitis Functional Index. J Rheumatol)]TJ
0 Tc 0 Tw T*
(1994;21:2281-5.)Tj
-0.00011 Tc 0.02499 Tw -1.75 -1.25 Td
[(15.)-500 (Mackay K, Mack C, Brophy S, Calin )55 (A. )18 (The Bath )55 (Ankylosing)]TJ
1.75 -1.25 Td
[(Spondylitis Radiology Index \(BASRI\). )55 (A)-220 (new)65 (, validated approach to)]TJ
T*
[(disease assessment. )55 (Arthritis Rheum 1998;41:2263-70.)]TJ
-1.75 -1.25 Td
[(16.)-500 (Krug H, )18 (T)70 (aurog J. HLA-B27 has no ef)18 (fect on the phenotypic )]TJ
1.75 -1.25 Td
(expression of progressive ankylosis in ank/ank mice. J Rheumatol)Tj
0 Tc 0 Tw T*
(2000;27:1257-9.)Tj
-0.00011 Tc 0.02499 Tw -1.75 -1.25 Td
[(17.)-500 (A. )55 (A)92 (wada H, )55 (Abi-Karam G, Baddoura R, Okais J, )55 (Attoui S. Clinical,)]TJ
1.75 -1.25 Td
(radiological and laboratory findings in Lebanese spondylarthropathy)Tj
T*
(patients according to HLA-B27 status. Joint Bone Spine)Tj
0 Tc 0 Tw T*
(2000;67:194-8.)Tj
0.0249 Tw -1.75 -1.25 Td
[(18.)-500 (Burden )55 (A, Javed S, Bailey M, Hodgins M, Connor M, )18 (T)35 (illman D.)]TJ
-0.00011 Tc 1.75 -1.25 Td
(Genetics of psoriasis: paternal inheritance and a locus on)Tj
T*
[(Chromosome 6p. J Invest Dermatol 1998;1)37 (10:958-60.)]TJ
-1.75 -1.25 Td
[(19.)-500 (Rahman P)111 (, Gladman D, Schentag C, Petronis )55 (A. Excessive paternal)]TJ
1.75 -1.25 Td
[(transmission in psoriatic arthritis. )55 (Arthritis Rheum 1999;42:1228-31.)]TJ
-1.75 -1.25 Td
[(20.)-500 (W)40 (right )18 (V)129 (, Moll J. Seronegative polyarthritis. )55 (Amsterdam;)]TJ
1.75 -1.25 Td
(Elsevier/North-Holland Publishing; 1976.)Tj
ET
0 0 0 0 k
408 770 150 -25 re
f*
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
ET
/GS2 gs
BT
/T1_3 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2003. All rights reserved.)Tj
ET
Q
BT
0 g
/GS3 gs
/T1_4 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS3 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS3 gs
-16.72996 0 Td
(Downloaded on March 28, 2024 from )Tj
ET
endstream
endobj
39 0 obj
<>stream
8;Z\7;/X?,#ikn#j>rLY?q_JF6=/R$@SKk3VLT+q1Y%*t,,3Mg0>nL6YMTT^c]F3t
='RmelX$ah4Ot7D?*>>aGIl2BWua],q>39*.7`FOelmfW=F34rL8uOOS_0RTKk8sk
QTaft?&],uEuU-P=_m8<0&$295ddamdf02X/EoX*cHVQ\.ATMPO?("Y>"$bllh?NR
,A&0\(5eIH;I.,GO0'+TI5$Z,Z*]S2'Q$53)AEPQYF+/0;tq)f>Z$uP9`1/XYJE&+
;hV=8]#]1s4m"HcSKQ1"g7kHoPXN9mg[LWSn'0
@s@s3L1R8XFYYM2T](OdmBeE<1L,XU)QW'5Hc&/(#!9l.:PKdEFTgY=)#0%S0r#L4
G>TfD*MKcHGRfd4CI;)3d/(\2/H]S9Z`VPT1cVr\0>cIVV5H(V5(eWr]UXY2VDI@=
Ng`e1K0J_Feq#cllg-[lqVLk$0N%LT(WN#k!$lEI3M'i7kJ6c[h8hRAltOJ%LC/Bh
1-`Ea4#\'o'-lEtTLq8Mc22RsEVgbXkHet0RBQh%ZkX?,-1R/lF0OZ95(@NjE,]c8
E,Z@2FhA>t'(IPs[FKFa=8Y.':rhGn.];Cr~>
endstream
endobj
43 0 obj
[/Indexed/DeviceRGB 255 42 0 R]
endobj
42 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
68 0 obj
<>
endobj
72 0 obj
<>
endobj
28 0 obj
<>
endobj
109 0 obj
<>
endobj
148 0 obj
<>
endobj
29 0 obj
<>
endobj
30 0 obj
<>stream
HLPw9v_lEY=I1WC!#'J wqwwX&zܝp bD@kTjIcN:11yv}oJpv癝w}>|$"#$c26X̮LX=M4GHF)r;B>:Y"ɨ3 K'$$r8[%EqԔԚ55(vl5\2m/rN`*7/S;<,T*VoS$c;ʫf>c
oxrUe-]'L
Gb$a"ɹd=}Ė#njr4]9R*hNnrB#gMߟx'ڟuXXw`Mֳ&9[J{3U{^w{}3,#/@$jnqJzJmI2+OC<O